The US Food and Drug Administration has issued guidance urging sponsors and trial sites to consider the necessity of the invasive procedure and gaining assent and consent from children ahead of trials ...
In a release issued under the same headline on Tuesday, January 7th by (NASDAQ: OSUR), please note that the first sentence of the release (read "OraQuick® HIV Self-Test that will increase access to ...
Results that may be inaccessible to you are currently showing.